Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NIRSAL is a non-bank financial institution wholly owned by the Central Bank of Nigeria. Its mandate is to stimulate affordable financing and investment into Nigeria’s agriculture sector by de-risking agricultural lending, building capacity across value chains, providing technical assistance, insurance products, incentives for lenders/investors, and rating services. It does not operate in drug discovery/development or healthcare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nigeria Incentive-Based Risk Sharing System for Agricultural Lending.